1. Active components from Lagotis brachystachya maintain uric acid homeostasis by inhibiting renal TLR4-NLRP3 signaling in hyperuricemic mice
- Author
-
Hai-Yan Yang, Yang Liu, Hong-Yu Cheng, Jie Cheng, Li-Tao Yi, Ji-Xiao Zhu, and Wei-Qiong Hu
- Subjects
Male ,Organic anion transporter 1 ,Immunology ,Hyperuricemia ,Pharmacology ,Kidney ,Protein Structure, Secondary ,Excretion ,Mice ,chemistry.chemical_compound ,NLR Family, Pyrin Domain-Containing 3 Protein ,medicine ,Animals ,Homeostasis ,Pharmacology (medical) ,Plants, Medicinal ,Dose-Response Relationship, Drug ,biology ,Glucose transporter ,medicine.disease ,Uric Acid ,Toll-Like Receptor 4 ,medicine.anatomical_structure ,chemistry ,Apigenin ,biology.protein ,Uric acid ,Luteolin ,Drugs, Chinese Herbal ,Signal Transduction - Abstract
Lagotis brachystachya Maxim is an herb widely used in traditional Tibet medicine. Our previous study indicated that total extracts from Lagotis brachystachya could lower uric acid levels. This study aimed to further elucidate the active components (luteolin, luteoloside and apigenin) isolated from Lagotis brachystachya and the underlying mechanism in vitro and vivo. The results showed that treatment with luteolin and luteoloside reversed the reduction of organic anion transporter 1 (OAT1) levels, while apigenin attenuated the elevation of urate transporter 1 (URAT1) and glucose transporter 9 (GLUT9) levels in uric acid-treated HK-2 cells, which were consistent with the finding in the kidney of potassium oxonate (PO)-induced mice. On the other hand, hepatic xanthine oxidase activity was inhibited by the components. In addition, all of these active components improved the morphology of the kidney in hyperuricemic mice. Moreover, molecular docking showed that luteolin, luteoloside and apigenin could bind TLR4 and NLRP3. Consistently, western blot showed that the components inhibited TLR4/MyD88/NLRP3 signaling. In conclusion, these results indicated that luteolin, luteoloside and apigenin could attenuate hyperuricemia by decreasing the production and increasing the excretion of uric acid, which were mediated by the inhibition of inflammatory signaling pathways.
- Published
- 2021